| Plants or compound | Effect on airways | Effect on pulmonary function tests | Reference(s) |
| No.3.1.6 Argemone mexicana | Inhibiting bronchospasm | | [27] | No.3.3.1 Baicalin | ↓ AHR, improving airway resistance and lung compliance | | [28, 29] | No.3.1.8 Biophytum sensitivum | Inhibiting histamine-induced bronchoconstriction | | [30] | No.3.1.9 Boswellia serrata | | ↑ FEV1, FVC, PEFR ↓ Episodes of asthmatic attacks | [31, 32] | No.3.1.13 Carum copticum | Bronchodilator effect | ↑ FEV1, PEF, MMEF, MEF75, MEF50, MEF25, and sGaw | [33] | No.3.3.3 Carvacrol | ↓ AHR | ↑FEV1, FVC, MMEF, PEF, MEF75, MEF50, and MEF25 | [34–36] | No.3.1.15 Crataegus pinnatifida | ↓ AHR | | [37] | No.3.1.16 Crocus sativus | ↓ AHR | | [38, 39] | No.3.1.17 Curcuma longa rhizome (curcumin) | ↓ AHR | | [40] | No.3.3.9 Gallic acid | ↓ AHR | | [41] | No.3.1.25 Ginkgo biloba | | Improved FEV1/FVC | [42] | No.3.1.26 Glycirizine glabra | ↓ AHR | Improved FVC and FEV1, ↓ PIF, PEF, TV, and EV | [43] | No.3.1.27 Hedera helix | ↓ Airway resistance | | [44] | No.3.3.11 Hesperetin | ↓ AHR | | [45] | No.3.1.36 Moringa oleifera | | Improvement of FVC, FEV1, FEV1/FVC, PEFR, FEF 25–75%, and MVV | [46] | No.3.3.22 Naringenine | ↓ AHR | | [47] | No.3.1.37 Nigella sativa | | ↑ FVC, FEV1, MMEF, MEF50, MEF75, and MEF25 | [48, 49] | No.3.2.43 Pimpinella anisum | Bronchodilator activity | | [50] |
|
|